Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Brunner

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Allergy|November 21, 2023
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergiesPeter Schmid-Grendelmeier, Melinda J Gooderham, Karin Hartmann, et al.
Frontiers in Medicine|July 17, 2023
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, et al.
The British Journal of Dermatology|August 12, 2024
Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypesSumanth Chennareddy, Katharina Rindler, John R Ruggiero, et al.
The Journal of Investigative Dermatology|July 27, 2016
In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed SkinMarie-Charlotte Brüggen, Wolfgang M Bauer, Bärbel Reininger, et al.
EMBO Molecular Medicine|September 14, 2014
Specific roles for dendritic cell subsets during initiation and progression of psoriasisElisabeth Glitzner, Ana Korosec, Patrick M Brunner, et al.
Frontiers in Medicine|August 2, 2021
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type PsoriasisMartin Bauer, Edith Lackner, Peter Matzneller, et al.
The Journal of Investigative Dermatology|April 10, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controlsYoni Sacknovitz, Maggie H Zhou, Joshua Kent, et al.
Acta Dermato-Venereologica|September 5, 2024
Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)April W Armstrong, Elisabeth Riedl, Patrick M Brunner, et al.
Frontiers in Immunology|March 15, 2021
Spontaneously Resolved Atopic Dermatitis Shows Melanocyte and Immune Cell Activation Distinct From Healthy Control SkinKatharina Rindler, Thomas Krausgruber, Felix M Thaler, et al.
Journal of Clinical Medicine|April 30, 2020
Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like FolliculitisTamara Quint, Patrick M Brunner, Christoph Sinz, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Allergy|November 21, 2023
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergiesPeter Schmid-Grendelmeier, Melinda J Gooderham, Karin Hartmann, et al.
Frontiers in Medicine|July 17, 2023
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, et al.
The British Journal of Dermatology|August 12, 2024
Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypesSumanth Chennareddy, Katharina Rindler, John R Ruggiero, et al.
The Journal of Investigative Dermatology|July 27, 2016
In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed SkinMarie-Charlotte Brüggen, Wolfgang M Bauer, Bärbel Reininger, et al.
EMBO Molecular Medicine|September 14, 2014
Specific roles for dendritic cell subsets during initiation and progression of psoriasisElisabeth Glitzner, Ana Korosec, Patrick M Brunner, et al.
Frontiers in Medicine|August 2, 2021
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type PsoriasisMartin Bauer, Edith Lackner, Peter Matzneller, et al.
The Journal of Investigative Dermatology|April 10, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controlsYoni Sacknovitz, Maggie H Zhou, Joshua Kent, et al.
Acta Dermato-Venereologica|September 5, 2024
Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)April W Armstrong, Elisabeth Riedl, Patrick M Brunner, et al.
Frontiers in Immunology|March 15, 2021
Spontaneously Resolved Atopic Dermatitis Shows Melanocyte and Immune Cell Activation Distinct From Healthy Control SkinKatharina Rindler, Thomas Krausgruber, Felix M Thaler, et al.
Journal of Clinical Medicine|April 30, 2020
Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like FolliculitisTamara Quint, Patrick M Brunner, Christoph Sinz, et al.
Pageof 9